Abbott Park, IL - Abbott Laboratories announced the launch of the next-generation Perclose ® suture-mediated vessel closure system, Perclose ProGlide TM, featuring a polypropylene monofilament suture.
LAS VEGAS — Percutaneous closure of large-bore arterial access sites was associated with positive outcomes compared with surgical cutdown, according to data presented at VIVA 17. The percutaneous ...
Use of the Perclose ProGlide suture-mediated closure strategy to achieve vascular access-site hemostasis after transfemoral TAVR results in fewer major vascular complications than does deployment of ...
Suture-based vascular closure devices (VCDs) can, in real-world practice, lead to complications and even death, analysis of a US Food and Drug Administration database confirms. These adverse outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results